Prostate News Archive
04-Nov-2011
Radiation Plus Hormone Therapy Extends Life in High-Risk Prostate Cancer
WEDNESDAY, Nov. 2 (HealthDay News) -- A combination of radiation and hormone therapy prolongs survival among men whose cancer has spread beyond the prostate, Canadian and U.K. researchers report. Adding radiotherapy boosts prostate cancer survival
LONDON (Reuters) - Adding radiotherapy to hormone drugs for prostate cancer patients significantly improves survival compared with hormone treatment alone, and the combination could save many lives if it were made standard practice, scientists said Thursday. Medivation surges on prostate cancer drug data
Medivation Inc. stock more than doubled in value Thursday after the biotechnology company said a clinical trial of its experimental prostate cancer pill is ending earlier than expected because the study showed the drug worked.
Back to Prostate News Archive
